Global X Genomics & Biotechnology ETF Rating $9.22 0.00 (-0.04%) As of 09:30 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock Global X Genomics & Biotechnology ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.GNOM Aggregate RatingModerate Buy 2.69Holdings in GNOM have an aggregate rating of Moderate Buy based on 388 analyst ratings issued in the past year covering 23 companies (79.3% of the portfolio).GNOM Aggregate Price Target$9.23High Prediction$9.23Average Prediction$9.23Low Prediction$9.23Holdings in GNOM have an aggregate price target of $9.23 and a range of $9.23 to $9.23 covering 23 companies (79.3% of the portfolio).GNOM Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy5 Buy rating(s)Moderate Buy14 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Global X Genomics & Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 23 GNOM Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.42%ALNYAlnylam Pharmaceuticals$453.22+0.4%4.1835 of 5 stars2.85$405.33 -10.6%26Positive News5.62%CRSPCRISPR Therapeutics$53.65-2.3%3.5447 of 5 stars2.47$71.60 33.5%17Positive NewsAnalyst Upgrade4.80%ILMNIllumina$99.67+0.1%4.6438 of 5 stars2.21$123.17 23.6%19Positive News4.56%QGENQiagen$46.12-5.6%4.0226 of 5 stars2.27$49.69 7.7%114.52%RNAAvidity Biosciences$47.85+0.1%2.9816 of 5 stars3.06$67.00 40.0%18Positive News4.37%LEGNLegend Biotech$34.89-0.5%3.901 of 5 stars2.91$74.22 112.7%11Positive NewsAnalyst Forecast4.23%TECHBio-Techne$56.17-1.1%4.8551 of 5 stars2.69$69.42 23.6%13Positive News4.02%MRNAModerna$25.05-0.2%4.5022 of 5 stars2.04$42.88 71.2%243.63%BMRNBioMarin Pharmaceutical$58.38-0.5%4.9963 of 5 stars2.72$93.17 59.6%25Positive News3.63%VRTXVertex Pharmaceuticals$389.00+0.5%4.9428 of 5 stars2.56$497.10 27.8%27Positive News3.61%BNTXBioNTech$102.80-0.2%2.892 of 5 stars2.76$135.80 32.1%17Positive News3.51%GHGuardant Health$63.94+0.7%3.1666 of 5 stars3.06$57.50 -10.1%17Positive News3.50%NTRANatera$162.66-1.8%3.1253 of 5 stars3.06$193.19 18.8%18Positive News3.20%WGSGeneDx$127.93+1.3%1.9295 of 5 stars2.75$101.63 -20.6%8Insider Trade2.94%RAREUltragenyx Pharmaceutical$30.17+0.3%4.6753 of 5 stars2.92$81.50 170.2%122.40%TWSTTwist Bioscience$27.52+1.2%3.9557 of 5 stars2.73$49.40 79.5%11Positive News2.30%VCYTVeracyte$28.75-1.1%2.3827 of 5 stars2.70$40.90 42.3%10Positive News2.30%ARWRArrowhead Pharmaceuticals$21.79+0.0%3.7552 of 5 stars3.00$43.14 98.0%9Positive News2.09%AAgilent Technologies$119.21+0.8%4.5948 of 5 stars2.50$138.67 16.3%12Trending NewsEarnings ReportAnalyst Forecast2.05%BEAMBeam Therapeutics$17.05+1.2%2.0394 of 5 stars3.07$48.45 184.1%14Positive News2.05%GILDGilead Sciences$113.18-1.4%4.9747 of 5 stars2.88$115.39 2.0%26Positive News1.77%LLYEli Lilly and Company$737.16+0.2%4.9993 of 5 stars2.67$950.17 28.9%24Trending NewsAnalyst Upgrade1.76%BMYBristol Myers Squibb$47.39+0.4%4.7496 of 5 stars2.24$56.38 19.0%21Positive News This page (NASDAQ:GNOM) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredSmall Washington, DC Group Could Crash US StocksNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredTrump's "Big Beautiful Bill" hides ugly truthWashington’s new “Big Beautiful Bill” promises tax breaks… but the fine print tells a different story: trillio...Defi Master | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Genomics & Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X Genomics & Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access